Rational Advisors LLC reduced its stake in shares of KKR & Co. Inc. (NYSE:KKR – Free Report) by 12.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 27,900 shares of the asset manager’s stock after selling 4,000 shares during the period. Rational Advisors LLC’s holdings in KKR & Co. Inc. were worth $3,643,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. OLD National Bancorp IN raised its stake in KKR & Co. Inc. by 1.3% in the 3rd quarter. OLD National Bancorp IN now owns 6,477 shares of the asset manager’s stock valued at $846,000 after acquiring an additional 85 shares during the period. Raleigh Capital Management Inc. increased its stake in shares of KKR & Co. Inc. by 56.7% in the 3rd quarter. Raleigh Capital Management Inc. now owns 235 shares of the asset manager’s stock valued at $31,000 after purchasing an additional 85 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in shares of KKR & Co. Inc. by 13.1% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 769 shares of the asset manager’s stock valued at $81,000 after purchasing an additional 89 shares in the last quarter. Crestwood Advisors Group LLC lifted its stake in shares of KKR & Co. Inc. by 2.1% in the 2nd quarter. Crestwood Advisors Group LLC now owns 4,658 shares of the asset manager’s stock valued at $490,000 after acquiring an additional 94 shares during the last quarter. Finally, Centaurus Financial Inc. grew its holdings in shares of KKR & Co. Inc. by 1.3% during the second quarter. Centaurus Financial Inc. now owns 7,715 shares of the asset manager’s stock worth $812,000 after purchasing an additional 98 shares during the last quarter. Institutional investors and hedge funds own 76.26% of the company’s stock.
Insider Transactions at KKR & Co. Inc.
In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the sale, the insider now owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other KKR & Co. Inc. news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the company’s stock in a transaction that occurred on Wednesday, September 11th. The shares were bought at an average cost of $11.13 per share, with a total value of $129,330,577.74. Following the completion of the transaction, the insider now directly owns 92,959,984 shares of the company’s stock, valued at approximately $1,034,644,621.92. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the transaction, the insider now directly owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 39.34% of the company’s stock.
KKR & Co. Inc. Stock Down 0.4 %
KKR & Co. Inc. (NYSE:KKR – Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The asset manager reported $1.38 EPS for the quarter, beating the consensus estimate of $1.03 by $0.35. The firm had revenue of $4.79 billion for the quarter, compared to analyst estimates of $1.23 billion. KKR & Co. Inc. had a return on equity of 5.86% and a net margin of 13.21%. During the same period in the prior year, the company earned $0.73 EPS. On average, equities analysts predict that KKR & Co. Inc. will post 4.01 EPS for the current fiscal year.
KKR & Co. Inc. Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be paid a dividend of $0.175 per share. The ex-dividend date is Monday, November 4th. This represents a $0.70 annualized dividend and a dividend yield of 0.51%. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 21.28%.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. Wells Fargo & Company lifted their target price on shares of KKR & Co. Inc. from $139.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Friday, October 25th. HSBC initiated coverage on KKR & Co. Inc. in a research report on Wednesday, September 18th. They set a “buy” rating and a $148.00 target price on the stock. Redburn Atlantic started coverage on shares of KKR & Co. Inc. in a research report on Tuesday, August 27th. They set a “buy” rating and a $153.00 price target on the stock. Barclays increased their price objective on shares of KKR & Co. Inc. from $149.00 to $166.00 and gave the company an “overweight” rating in a research note on Friday, October 25th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on KKR & Co. Inc. from $128.00 to $141.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $151.64.
Get Our Latest Stock Analysis on KKR & Co. Inc.
About KKR & Co. Inc.
KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Recommended Stories
- Five stocks we like better than KKR & Co. Inc.
- About the Markup Calculator
- Intel: Is Now the Time to Be Brave?Â
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.